HIC1 Tumor Suppressor Loss Potentiates TLR2/NF-κB Signaling and Promotes Tissue Damage-Associated Tumorigenesis
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
25934696
DOI
10.1158/1541-7786.mcr-15-0033
PII: 1541-7786.MCR-15-0033
Knihovny.cz E-zdroje
- MeSH
- azoxymethan MeSH
- epitelové buňky MeSH
- genový knockdown MeSH
- karcinogeneze metabolismus MeSH
- lidé MeSH
- modely nemocí na zvířatech MeSH
- myši transgenní MeSH
- myši MeSH
- nádorové buněčné linie MeSH
- nádorové supresorové proteiny metabolismus MeSH
- nádory tračníku MeSH
- NF-kappa B metabolismus MeSH
- proliferace buněk MeSH
- signální transdukce * MeSH
- síran dextranu MeSH
- střeva cytologie MeSH
- toll-like receptor 2 metabolismus MeSH
- transkripční faktory Krüppel-like genetika metabolismus MeSH
- upregulace MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- azoxymethan MeSH
- Hic1 protein, mouse MeSH Prohlížeč
- nádorové supresorové proteiny MeSH
- NF-kappa B MeSH
- síran dextranu MeSH
- Tlr2 protein, mouse MeSH Prohlížeč
- toll-like receptor 2 MeSH
- transkripční faktory Krüppel-like MeSH
UNLABELLED: Hypermethylated in cancer 1 (HIC1) represents a prototypic tumor suppressor gene frequently inactivated by DNA methylation in many types of solid tumors. The gene encodes a sequence-specific transcriptional repressor controlling expression of several genes involved in cell cycle or stress control. In this study, a Hic1 allele was conditionally deleted, using a Cre/loxP system, to identify genes influenced by the loss of Hic1. One of the transcripts upregulated upon Hic1 ablation is the toll-like receptor 2 (TLR2). Tlr2 expression levels increased in Hic1-deficient mouse embryonic fibroblasts (MEF) and cultured intestinal organoids or in human cells upon HIC1 knockdown. In addition, HIC1 associated with the TLR2 gene regulatory elements, as detected by chromatin immunoprecipitation, indicating that Tlr2 indeed represents a direct Hic1 target. The Tlr2 receptor senses "danger" signals of microbial or endogenous origin to trigger multiple signaling pathways, including NF-κB signaling. Interestingly, Hic1 deficiency promoted NF-κB pathway activity not only in cells stimulated with Tlr2 ligand, but also in cells treated with NF-κB activators that stimulate different surface receptors. In the intestine, Hic1 is mainly expressed in differentiated epithelial cells and its ablation leads to increased Tlr2 production. Finally, in a chemical-induced mouse model of carcinogenesis, Hic1 absence resulted in larger Tlr2-positive colonic tumors that showed increased proportion of proliferating cells. IMPLICATIONS: The tumor-suppressive function of Hic1 in colon is related to its inhibitory action on proproliferative signaling mediated by the Tlr2 receptor present on tumor cells.
Citace poskytuje Crossref.org
HIC1 Expression Distinguishes Intestinal Carcinomas Sensitive to Chemotherapy